Canada fails to curb pharma costs
Lancet World Report Canada Drug Cost Reforms Collapse, May 12, 2023
Posts in category Access to Affordable Medicines
11 studies shaping 2023 medicine
Leading researchers name their top clinical trial for 2023, from cervical and prostate cancer screening to new drugs for Parkinson’s disease and Alzheimer’s disease.
A Golden Age for Cancer Research: Nature Medicine April 19 2022
Golden Age in Cancer Research April 19 2022 Nature Medicine
Access to Affordable MedicinesAddiction, Depression, Psychosis, SchizophreniaBusinessDigital HealthEpidemics & PandemicsHealthcare PoliticsHealthcare Privatization: A Global Business Campaign
Medicare’s Public-Private Virtualization (The Logic, Nov 27 2021)
For Telus CEO Darren Entwistle, virtual health is personal – The Logic
Access to Affordable MedicinesAntibiotic ResistanceCanadian Science PolicyDiseases of NeglectDrug PoliticsEpidemics & PandemicsGlobal HealthHealthcare PoliticsInternational DevelopmentScience
Nature Medicine: Biomedical research during the COVID lockdown
Government-funded medical research bodies in the UK, Europe, USA and Australia say they are committed to maintaining funding continuity for biomedical research. So far, only in Canada has a major …
Access to Affordable MedicinesAddiction, Depression, Psychosis, SchizophreniaBusinessDrug PoliticsHealthcare Politics
Psychedelic therapies?
Lancet May 19 2019 Psychedelic therapy
Access to Affordable MedicinesAddiction, Depression, Psychosis, SchizophreniaDrug PoliticsHealthcare Politics
Canada’s expanding cannabis market sparks worries
Lancet Jan 12 2019 Canada’s expanding cannabis market